Don J. Mizerk
Husch Blackwell LLPGeneral
Experience25 yrs
Elite Ratings
--
Practice Areas
Chemical Biotech (3 cases)
Biotech (67 cases)
Chemical (3 cases)
Comp. Arch. and Software (7 cases)
Communications (1 case)
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
--
--
--
CAFC
L3
E
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 2:26-CV-01084 | Saptalis Pharmaceuticals LLC v. MSN Pharmaceuticals Inc | 02/03/26 | Patent Owner | |
| 1:24-CV-00700 | Merck KGaA v. TWi Pharma Inc | 06/14/24 | Challenger | |
| 2:23-CV-20935 | Novo Nordisk Inc v. ScinoPharm Taiwan Ltd | 10/05/23 | Challenger | |
| 1:23-CV-20935 | Novo Nordisk INC. v. ScinoPharm Taiwan LTD. | 10/05/23 | Challenger | |
| 2:23-CV-09763 | Alkermes Pharma Ireland Ltd v. Nanjing Delova Biotech Co Ltd | 08/24/23 | Challenger | |
| 1:23-CV-00401 | Novartis Pharma Corp v. Nanjing Noratech Pharmaceutical Co Ltd | 04/10/23 | ||
| 1:23-CV-00199 | Upsher Smith Laboratories LLC v. Xiamen LP Pharmaceutical Co Ltd | 02/23/23 | Challenger | |
| 3:22-CV-06968 | Bristol Myers Squibb Co v. Handa Oncology LLC | 11/07/22 | Challenger | |
| 1:22-CV-01395 | Novartis Pharma Corporation v. MSN Pharma Inc. | 10/24/22 | ||
| 8:22-CV-00979 | MGI Digital Technology SA v. Duplo USA Corp | 05/12/22 |